Trevi Therapeutics, Inc. Ttl Offset Amt
Trevi Therapeutics, Inc. (TRVI) had Ttl Offset Amt of $0 as of 2026-08-06, per its S-8 filed 2026-08-06.
Financial Statements › Notes
ffd:TtlOffsetAmt · last filed 2026-08-06
- 2026-08-06: Ttl Offset Amt $0.00.
- 2026-04-17: Ttl Offset Amt $0.00.
| Period end | Ttl Offset Amt |
|---|---|
| 2026-08-06 | $0.00 S-8 · filed 2026-08-06 |
| 2026-04-17 | $0.00 424B5 · filed 2026-04-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |